cardiovascular safety of glucoselowering agents as addon medication to metformin treatment in type 2 diabetes report f.心血管安全的降糖药物的附加药物二甲双胍治疗2型糖尿病的报告瑞.pdfVIP

Received: 21 February 2016 Revised: 26 May 2016 Accepted: 4 June 2016 DOI 10.1111/dom.12704 O R I G I N A L A R T I C L E Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register Nils Ekström MD, PhD1,2 | Ann-Marie Svensson RN, PhD3 | Mervete Miftaraj MSC3 | Stefan Franzén PhD3 | Björn Zethelius MD, PhD4,5 | Björn Eliasson MD, PhD1